title: Nutritional therapy for selected inborn errors of metabolism.
abstract: Nutritional approaches are available for the management of several different classes of inborn metabolism errors. In phenylketonuria (PKU), phenylalanine is not properly metabolized; and its accumulation leads to neurologic dysfunction and metal retardation. Altering the diet to limit phenylalanine intake led to remarkable improvement in children with PKU. It was later found that instituting dietary therapy immediately after identification of the disorder in newborns prevented mental retardation. Throughout the 1960s nutritional therapies were found for other inborn disorders, including galactosemia, maple syrup urine disease, and homocystinuria. For the group of disorders associated with defects in the urea cycle, leading to profound hyperammonemia, therapy based on the concept of waste nitrogen excretion (i.e., by increasing excretion of urea cycle intermediates in the urine, nitrogen that would otherwise recycle as ammonia can be eliminated) dramatically produced better control of hyperammonemia and its consequences. Some inborn errors of metabolism respond to vitamin therapy. Biotin-related multiple carboxylase synthetase deficiency can be produced by either of two enzyme defects--holocarboxylase synthetase deficiency or biotinidase deficiency. Both are treatable with biotin supplementation. The symptoms of multiple carboxylase deficiency can also occur after intestinal resection or ingestion of raw eggs. Multiple carboxylase deficiency has been treated successfully in utero by giving the mother biotin supplements. Peroxisomal disorders may respond to dietary management. Liver disease in hereditary tyrosinemia may be accentuated by hypermethioninemia and treated by controlling the blood methionine level. Glycogen storage disease Type I, which causes hypoglycemia, can be controlled by oral administration of cornstarch.
authors.affiliation: Harvard Medical School, Boston, Massachusetts.
authors.forename: H L
authors.initials: HL
authors.lastname: Levy
mesh_terms: D005953:Glycogen Storage Disease Type I / Q000178:diet therapy; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000178:diet therapy*; D008830:Microbodies; D009100:Multiple Carboxylase Deficiency / Q000178:diet therapy; D009747:Nutritional Physiological Phenomena; D012106:Research; D014443:Tyrosine / Q000097:blood; D014508:Urea / Q000378:metabolism
chemical_list: D014443:Tyrosine; D014508:Urea